3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
3/3 莫尔豪斯医学院/塔斯基吉大学/阿拉巴马大学 Ca Ctr 合作伙伴关系
基本信息
- 批准号:9357529
- 负责人:
- 金额:$ 117.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-30 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAffectAfrican AmericanAlabamaAwardBasic ScienceBehavioralBioethicsBioinformaticsBioinformatics Shared ResourceBiological SciencesBiometryCancer BiologyCancer BurdenCancer Center Planning GrantCancer EtiologyCancer Research ProjectCancer SurvivorCaregiversCaringClinicalClinical ResearchCollaborationsCommunitiesCommunity Health EducationCommunity Health SystemsComplementComprehensive Cancer CenterDeep SouthDevelopmentDietEducation and OutreachEducational CurriculumEnrollmentEnsureEthicsEvaluationExtramural ActivitiesFacultyFoundationsFundingGoalsGrantHeartHospitalsInstitutionLinkMalignant NeoplasmsManuscriptsMetastatic Prostate CancerMinority RecruitmentMolecularMorehouse School of MedicineOutcomeOutreach ResearchPatientsPhysical activityPilot ProjectsPoliciesPopulationPopulation HeterogeneityPostdoctoral FellowPublicationsPublishingRecording of previous eventsResearchResearch PersonnelResearch Project GrantsResource SharingResourcesRisk ReductionRuralScientistSecureTestingTherapeutic TrialsTrainingTraining ProgramsUnderserved PopulationUniversitiesVisionanticancer researchbasebiological researchcancer carecancer educationcancer health disparitycancer riskcareercolorectal cancer screeningeducation planningeducation researchethnic minority populationevidence basefaculty researchgraduate studenthealth disparityhealthy lifestyleimprovedinnovationinterestmembermenminority investigatorminority studentmultidisciplinarynew therapeutic targetnext generationoutreachoutreach programpre-clinicalprogramsracial and ethnicsatisfactionsocialsuccesssymposiumtraditional careundergraduate student
项目摘要
PROJECT SUMMARY/ABSTRACT:
This type-2 application is to strengthen and build upon the established U54 Partnership between Morehouse
School of Medicine (MSM), Tuskegee University (TU), and the UAB Comprehensive Cancer Center
(UABCCC). The Partnership, located in the heart of the Southeast, a region with a large, historically
underserved, African American population, has the overall goal of attaining excellence in research focused on
elimination of cancer health disparities and on reducing the cancer burden among underserved populations in
the region. The partnering institutions possess unique strengths that complement each other in achieving the
proposed goal through integrated research, education, and outreach. The primary objectives are to enhance
productive cancer research programs, to develop a pipeline of racial/ethnic minority investigators in cancer
research at MSM and TU, and to increase the level of involvement of investigators conducting research on
cancer disparities at the UAB CCC. The Partnership has four Cores (Administrative, Outreach, Research
Education, and Planning & Evaluation); two Full Research Projects; a Pilot Research Project; and two Shared
Resources (Bioethics and Biostatistics/Bioinformatics). With these assets and activities, the Partnership will: 1)
through the full projects, identify molecular mechanisms and new therapeutic targets for metastatic prostate
cancer, which is present at a higher rate in African American men, and, through the pilot project, adapt the
current, successful patient navigation program for racial/ethnic minority recruitment at the UAB CCC for
implementation at the MSM and Grady Hospital; 2) through the Outreach Core, apply an innovative cancer
survivor care plan at MSM, TU, and the UAB CCC by linking community- and health system-based patient
navigators and advisors to improve satisfaction with care, and implement culturally appropriate community
health education for cancer survivors and caregivers; 3) through the Research Education Core, employ an
integrated cancer research education program that involves capacity building and linkages to undergraduate
and graduate students and junior faculty, allowing them to pursue careers in cancer research; and 4) provide
funding for additional Pilot Research projects. The Planning & Evaluation Core will continually assess/evaluate
the outcomes of the cores, research projects, and shared resources. The Bioethics Shared Resource will
promote and ensure adherence to bioethical principles and address ethical considerations in relationships
between the institutions and between the institutions and communities. The Biostatistics/Bioinformatics Shared
Resource will deliver statistical and bioinformatics support for all activities. Together, we will contribute to
elimination of cancer health disparities.
项目总结/文摘:
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Birrer其他文献
Michael Birrer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Birrer', 18)}}的其他基金
Proteomic, Genomic, and Longitudinal Pathways to Ovarian Cancer Biomarker Discovery
卵巢癌生物标志物发现的蛋白质组学、基因组学和纵向途径
- 批准号:
10426776 - 财政年份:2021
- 资助金额:
$ 117.05万 - 项目类别:
Validation of a genomic signature that predicts for sub-optimal debulking of epithelial ovarian cancer
验证预测上皮性卵巢癌次优减灭的基因组特征
- 批准号:
10150186 - 财政年份:2018
- 资助金额:
$ 117.05万 - 项目类别:
Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit
蛋白质组学研究旨在了解卵巢肿瘤对针对 DNA 损伤反应的药物的反应,并将这些知识转化为临床益处
- 批准号:
10602812 - 财政年份:2017
- 资助金额:
$ 117.05万 - 项目类别:
Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit
蛋白质组学研究旨在了解卵巢肿瘤对针对 DNA 损伤反应的药物的反应,并将这些知识转化为临床益处
- 批准号:
9271779 - 财政年份:2017
- 资助金额:
$ 117.05万 - 项目类别:
Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit
蛋白质组学研究旨在了解卵巢肿瘤对针对 DNA 损伤反应的药物的反应,并将这些知识转化为临床益处
- 批准号:
10287121 - 财政年份:2017
- 资助金额:
$ 117.05万 - 项目类别:
The FGF18/FGFR4 amplicon: Novel therapeutic biomarkers for ovarian cancer
FGF18/FGFR4 扩增子:卵巢癌的新型治疗生物标志物
- 批准号:
8817261 - 财政年份:2013
- 资助金额:
$ 117.05万 - 项目类别:
The FGF18/FGFR4 amplicon: Novel therapeutic biomarkers for ovarian cancer
FGF18/FGFR4 扩增子:卵巢癌的新型治疗生物标志物
- 批准号:
9588790 - 财政年份:2013
- 资助金额:
$ 117.05万 - 项目类别:
The FGF18/FGFR4 amplicon: Novel therapeutic biomarkers for ovarian cancer
FGF18/FGFR4 扩增子:卵巢癌的新型治疗生物标志物
- 批准号:
8501801 - 财政年份:2013
- 资助金额:
$ 117.05万 - 项目类别:
The FGF18/FGFR4 amplicon: Novel therapeutic biomarkers for ovarian cancer
FGF18/FGFR4 扩增子:卵巢癌的新型治疗生物标志物
- 批准号:
9025469 - 财政年份:2013
- 资助金额:
$ 117.05万 - 项目类别:
Proteomic Genetic and Longitudinal Paths to Ovarian Cancer Biomarker Discovery
卵巢癌生物标志物发现的蛋白质组遗传学和纵向路径
- 批准号:
8147825 - 财政年份:2010
- 资助金额:
$ 117.05万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 117.05万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 117.05万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 117.05万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 117.05万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 117.05万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 117.05万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 117.05万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 117.05万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 117.05万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 117.05万 - 项目类别:
Fellowship Programs














{{item.name}}会员




